Journal Report

LANCET INFECTIOUS DISEASES

Download PDF
Journal Information
Journal Title
LANCET INFECTIOUS DISEASES
Publisher
ELSEVIER SCI LTD
ISSN
1473-3099
E-ISSN
1474-4457
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Empiric tuberculosis treatment in hospitalised adults with advanced HIV disease in Africa: applying the therapeutic threshold to clinical practice
Tom Boyles, Jayne Ellis, Nicholas Feasey et al.
2026-11 Vol. 26 Issue 11 Pages e477-e483
DOI: 10.1016/s1473-3099(26)00351-8
Dora Buonfrate—making strongyloidiasis less neglected
Tony Kirby
2026-11 Vol. 26 Issue 11 Pages 1096
DOI: 10.1016/s1473-3099(26)00537-2
Humoral immunity after mRNA SARS-CoV-2 XFG vaccination
Christine Happle, Markus Hoffmann, Metodi V Stankov et al.
2026-11
DOI: 10.1016/s1473-3099(26)00569-4
Research in brief
Priya Venkatesan
2026-11 Vol. 26 Issue 11 Pages e452
DOI: 10.1016/s1473-3099(26)00543-8
Momentum builds for the global elimination of trachoma
Timothy Jesudason
2026-11 Vol. 26 Issue 11 Pages e450
DOI: 10.1016/s1473-3099(26)00541-4
Vasee Moorthy
Udani Samarasekera
2026-11 Vol. 26 Issue 11 Pages 1095
DOI: 10.1016/s1473-3099(26)00536-0
Andes virus management—balancing infection control with patient safety and autonomy
Gregory J Mertz, Pablo A Vial, Michelle S Harkins
2026-11
DOI: 10.1016/s1473-3099(26)00581-5
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial
Hong-Xing Pan, Zhao-Feng Bi, Yu-Lin Jing et al.
2026-11 Vol. 26 Issue 11 Pages 1190-1202
DOI: 10.1016/s1473-3099(26)00221-5
Nine-valent human papillomavirus vaccine: implications for cervical elimination
Punnee Pitisuttithum, Rakesh Aggarwal
2026-11 Vol. 26 Issue 11 Pages 1093-1094
DOI: 10.1016/s1473-3099(26)00256-2
Mucocutaneous leishmaniasis caused by Leishmania infantum in a Norwegian patient receiving TNF-α inhibitor therapy
Jakob Lillemoen Drivenes, Jone Holm Grasdal, Lene Frøyen Sandvik et al.
2026-11 Vol. 26 Issue 11 Pages e494-e495
DOI: 10.1016/s1473-3099(26)00428-7
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 13, 2026 20:22